Market Tracker

11/17 5:15pm ET

Acer Therapeutics Inc (NASDAQ:ACER)

17.75
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
5.64
Today|||52-Week Range
22.63
+86.31%
Year-to-Date
No recent news for Acer Therapeutics Inc.

Today’s Trading

Previous close17.75
Today’s open17.20
Day’s range17.00 - 18.29
Volume12,140
Average volume (3 months)21,653
Market cap$114.5M
Dividend yield--
Data as of 3:59pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)+44.88%
Earnings growth (this year)+58.41%
Earnings growth (next 5 years)--
Revenue growth (last year)+13.65%
P/E ratioNM
Price/Sales2.23
Price/Book4.52

Competitors

 Today’s
change
Today’s
% change
MBVXMabVax Therapeutics ...0.000.00%
CPHIChina Pharma Holding...0.000.00%
SSKNSTRATA Skin Sciences...0.000.00%
NEOTNeothetics Inc0.000.00%
Data as of 4:00pm ET, 11/17/2017

Financials

Last reporting dateNovember 13, 2017
EPS forecast (this quarter)-$1.24
Annual revenue (last year)$2.9M
Annual profit (last year)-$8.0M
Net profit margin-274.69%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Christopher Schelling
Chief Financial Officer
Harry S. Palmin
Corporate headquarters
Cambridge, Massachusetts

Forecasts